Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease

Neuroscience Letters

Volumn 259, Issue 2, 1999, Pages 133-135

  Green, A J E ^a   Harvey, R J ^a   Thompson, E J ^a   Rossor, M N ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Dementia; Frontotemporal dementia; Pick's disease; Tau

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; TEMPORAL CORTEX;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS; TEMPORAL LOBE;

EID: 0033534519     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00904-5     Document Type: Article

References (20)

1. Andreasen N., Vanmechelen E., van de Voorde A., Davidsson P., Hesse C., Tarvonen S., Raha I., Sourander L., Winblad B., Blennow K. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J. Neurol. Neurosurg. Psychiatry. 64:1998;298-305.
2. Arai H., Morikawa Y., Higuchi M., Matsui T., Clark C.M., Miura M., Machida N., Lee V.M.Y., Trojanwski J.Q., Sasaki H. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys Res. Commun. 236:1997;262-264.
3. Arai H., Terajima M., Miura M., Higuchi S., Muramatsu T., Machida N., Seki H., Takase S., Clark C.M., Lee V.M.Y., Trojanowski J.Q., Sasaki H. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann. Neurol. 38:1995;649-652.
4. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease? Mol. Chem. Neuropathol. 26:1995;231-245.
5. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., Davies P. Correlations of synaptic markers with cognitive status in prospectively studied elderly humans. Neurobiol. Aging. 16:1995;285-298.
6. Folstein M., Folstein S., McHughs P. The 'Mini mental state': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
7. Galasko D., Clark C., Chang L., Miller B., Green R.C., Motter R., Seubert P. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology. 48:1997;632-635.
8. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurol. Sci. 11:1993;460-465.
9. Goedert M., Crowther R.A., Garner C.C. Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci. 14:1991;193-199.
10. Hutton M., Lendon C.L., Baker M., Froelich S., Houlden H., Pickering Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
11. Knopman D.S., Mastri A.R., Frey W.H., Sung J.H., Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 40:1990;251-266.
12. Litvan I., Agid Y., Sastri N., Jankovic J., Wenning G.K., Goetz C.G., Verny M., Brandel J.P., Jellinger K., Chaudhuri K., McKee A., Lai E.C., Pearce R.K.B., Bartko J.J. What are the obstacles for an accurate clinical diagnosis of Pick's disease. A clinicopathologic study, Neurology. 49:1997;62-68.
13. Mann D.M.A., South P.W., Snowden J.S., Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J. Neurol. Neurosurg. Psychiatry. 56:1993;605-614.
14. McKhan G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA work group under the auspices of The Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
15. Mitani K., Furiya Y., Uchihara T., Ishii K., Yamanouchi H., Mizusawa H., Mori H. Increased CSF tau protein in corticobasal degeneration. J. Neurol. 245:1998;44-46.
16. Neary D., Snowden J.S., Northen B., Goulding P. Dementia of frontal type. J. Neurol. Neurosurg. Psychiatry. 51:1988;353-361.
17. The Lund and Manchester Groups, Clinical and neuropathological criteria for frontotemporal dementia, J. Neurol. Neurosurg. Psychiatry, 57 (1994) 416-418.
18. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., Weber T., Kretzschmar T., Poser S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci. Lett. 225:1997;210-221.
19. Vandermeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martin J., Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61:1993;1828-1834.
20. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 45:1995;788-793.